Screening and risk of hepatocellular carcinoma in patients with advanced fibrosis after hepatitis C virus eradication.
Silvia EspinaDiego Casas DezaBelén Julián GomaraCristina Victoria Borao LagunaOlivia Sierra GabardaLuis Javier Lamuela CalvoSara LorenteTrinidad SerranoJosé Miguel Arbonés MainarVanesa Bernal MonterdePublished in: Revista espanola de enfermedades digestivas (2024)
post-SVR follow-up of patients with F3 fibrosis is variable in clinical practice. Using the FIB-4 after SVR allows us to identify those patients with a higher risk of HCC who benefit from biannual ultrasound screening.